Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Concordia Healthcare closes US$67.6 million bought deal public offering

Reading Time 1 minute read Subscribe



Concordia Healthcare Corp.

On March 11, 2014, Concordia Healthcare Corp. (the “Corporation”) announced that it had completed its previously announced short form prospectus offering on a “bought deal” basis of 5,750,000 common shares (the “Common Shares”) of the Corporation, which included the exercise of an over-allotment option of 15%, for aggregate gross proceeds to the Corporation of $67,562,500 (the “Offering”). The Offering was completed at a price per Common Share of $11.75 by a syndicate of underwriters co-led by GMP Securities L.P. and Canaccord Genuity Corp. and including Barclays Capital Canada Inc., Beacon Securities Limited and Cormark Securities Inc. The Corporation was represented by a team of Fasken Martineau lawyers that included Rubin Rapuch, John Sabetti, Francesco Tallarico and Aidan Hyde (capital markets) and Mitchell Thaw (tax).



    Receive email updates from our team